Natera
Mixed Month for Diagnostics Stocks as 360Dx Top 30 Ticks up 1 Percent in November
Out of the 30 companies tracked by 360Dx, 13 saw their share prices increase, while 17 saw their stock prices decline.
Top Five Articles on 360Dx Last Week: Agilent Reorganizes; Guardant Health Awarded $292.5M; More
Last week, readers were most interested in a story about Agilent changing two of its three business organizations to accelerate growth.
Natera Prospera Lung Test Receives Medicare Coverage for Single Lung Transplant Patients
The test was launched in 2022 and received coverage for double-lung transplant patients in 2023.
Jury Awards Guardant Health $292.5M in False Advertising Lawsuit Against Natera
The companies have both claimed that the other has engaged in false advertising related to Signatera and Reveal MRD assays.
Natera Q3 Revenues Grow 64 Percent
Strong product sales, mainly from oncology tests, drove the company's revenue growth, prompting it to raise its full year guidance.
Aug 1, 2024
360Dx Top 30 Jumps 11 Percent in July
Jun 5, 2024
Mar 1, 2024
360Dx Top 30 Creeps up 1 Percent in February
Feb 28, 2024